Story perspectives
Roche CEO Urges Switzerland to Align Drug Prices with US
12/22/2025
1 of 1
Story summary
- Roche Chief Executive Thomas Schinecker urged Switzerland to raise drug prices to align with United States levels.
- He warned that failure to raise prices could delay the introduction of new medicines.
- Schinecker noted that the pharmaceutical industry's tax revenues exceed spending on innovative medicines.
- Without higher prices, Roche would generate less revenue, reducing its ability to invest in research and potentially leading to fewer jobs.
